Transjugular Intrahepatic Portosystemic Shunt Is Associated With Better Waitlist Management of Liver Transplant Candidates With Hepatocellular Carcinoma

Transjugular intrahepatic portosystemic shunt (TIPS) reduces portal hypertension complications. Its impact on hepatocellular carcinoma (HCC) remains unclear. We evaluated 42,843 liver transplant candidates with HCC from the Scientific Registry of Transplant Recipients (2002–2022). 4,484 patients wit...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Sofia El Hajji, Stéphanie Lacotte, Beat Moeckli, François Cauchy, Philippe Compagnon, Christian Toso
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2024-06-01
Serie:	Transplant International
Soggetti:	liver transplantation recurrence survival progression hepatocellular carcinoma
Accesso online:	https://www.frontierspartnerships.org/articles/10.3389/ti.2024.12781/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!